(Date:12/3/2009)... 3 Nikon Corporation, an innovator of advanced ... a licensing agreement with Harvard University granting Nikon ... Microscopy (STORM) technology. Under the terms of the ... and market them with the N-STORM name. ...
(Date:12/3/2009)... VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ), a ... the treatment of cardiovascular and metabolic disease, today announced ... its Phase 2 FDG-PET clinical trial of VIA-2291. ... carried out at five sites in the US and ...
(Date:12/3/2009)... Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today announced that ... of fiscal year 2010 on December 10, 2009 at 7:00 ... to discuss the results at 11:30 a.m. EST on the ... for the second quarter ended October 31, 2009 and will ...
(Date:12/3/2009)... HOPKINTON, Mass., Dec. 3 Caliper Life Sciences, Inc. ... and services for drug discovery and life sciences research, ... vivo imaging systems. Living Image software drives the more ... worldwide. Living Image 4.0 features advanced spectral unmixing tools ...
Breaking Biology Technology:Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Caliper Life Sciences Launches Living Image(R) 4.0 Software 2... Ala., Dec. 5 BioCryst Pharmaceuticals (Nasdaq: BCRX ... on Forodesine HCl and BCX-4208, and clinical data on BCX-4208 ... and Exposition being held in San Francisco, CA from December ... nucleoside phosphorylase (PNP) inhibitors. , , ...
... Dec. 4 Medivation, Inc.,(Nasdaq: MDVN ) today announced that ... on two panels at the RBC Capital,Markets 2008 Healthcare Conference on Thursday, ... -- "Waging A Battle Against Cancer" from 8:00-8:55 a.m. Eastern Time, ... Time, , ...
... countries , , SEATTLE, and ... and the nonprofit global health organization PATH announced today a ... will initially invest $3 million over 27 months and work ... (VLP) prototype pandemic influenza vaccine. , , ...
Other Biology Technology:BioCryst to Present Three Posters During the 50th American Society of Hematology Annual Meeting and Exposition 2BioCryst to Present Three Posters During the 50th American Society of Hematology Annual Meeting and Exposition 3Medivation Announces Participation in RBC Capital Markets 2008 Healthcare Conference 2Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza 2Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza 3... Mouse monoclonal [RET-P1] to Rhodopsin Rhodopsin ... pigment in mammals, birds, amphibians, and reptiles. ... photoreceptor cells in the retina. ... retina. Specificity: This antibody ...
... Stabilizer is an aqueous solution that contains ... chemicals in a PBS buffer (phosphate buffered ... product does not contain a preservative. ... activity of dried protein components in immunoassays ...
...
... analysis software with the DeCypher Engine accelerator cards ... can perform searches like these from your desktop: ... in under 6 days Align BAC-sized ... Use HMM analysis to compare 100,000 sequences to ...
Biology Products: